Skip to main
UNH
UNH logo

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 22 analyst ratings
Buy
Strong Buy 23%
Buy 59%
Hold 9%
Sell 9%
Strong Sell 0%

Bulls say

UnitedHealth Group's stock outlook remains positive due to expected improvements in Value-Based Care (VBC) margins, projected to increase from approximately 1% to 5% over time, bolstered by a significant share of Year 1-2 patients in the Optum franchise. The company's anticipated earnings per share (EPS) growth, described as "strengthening quickly" for 2027, aligns with expectations of favorable outcomes from upcoming CMS Star ratings, potentially enhancing overall performance. Furthermore, UnitedHealth's strong balance sheet and considerable free cash flow position the company for effective capital deployment, which is expected to reinforce its robust core financial trends.

Bears say

UnitedHealth Group faces significant challenges, particularly with expected regression in Medicaid margins and conservative outlooks around Medicare Advantage (MA) cost assumptions, leading to a downward revision of 2026 earnings per share by 20%. The company's commercial margins are currently operating between 6-7%, falling approximately 100 basis points below their long-term target of 7-9%, with further shortfalls anticipated in 2025 due to changes in Health Insurance Exchange (HIX) regulations. Additionally, Optum Health is struggling, reporting margins at 3%, well below the adjusted target range of 6-8%, highlighting ongoing operational pressures that may hinder performance across its healthcare services divisions.

UnitedHealth Group (UNH) has been analyzed by 22 analysts, with a consensus rating of Buy. 23% of analysts recommend a Strong Buy, 59% recommend Buy, 9% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 22 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $396.77, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $396.77, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.